skip to content

Midatech Pharma

16:57 on 17/11/2017

Current Price 45.00p | Bid 45.00p | Ask 46.00p | Change 0.00%

Company Overview

Midatech Pharma plc is a UK incorporated nanomedicine company focused on the development and commercialisation of multiple therapeutic products to enhance the delivery of medicines in major diseases with high unmet medical needs. These diseases include diabetes, certain cancers such as liver, ovarian and brain (glioblastoma) and ophthalmologic conditions. The Group's two platform technologies are designed to enable targeted delivery and sustained release of existing therapeutic drugs. The Group's core technology platform is based on a patented form of gold nanoparticles that are developed to improve key parameters of existing and new drugs, target individual cell types with specific targeting agents and deliver a therapeutic payload in the cell, while ensuring this can be achieved safely. The Group's secondary platform of sustained release technology involves the consistent and precise encapsulation of active drug compounds within polymer microspheres. The microspheres are designed to release the active drug compound into the body in a highly controlled manner over a prolonged period of time, from a number of weeks to three months and potentially longer. The Group's sustained release technology platform will be acquired through Midatech's acquisition of Q Chip Limited, effective upon admission to AIM. The Group has developed a strong intellectual property base, operates a nanoparticle manufacturing facility, based in Bilbao, Spain, and is collaborating with a number of universities, speciality and major pharmaceutical companies to develop its platform technologies into a broad number of products in order to achieve a range of potential revenue opportunities within priority therapeutic areas.

Stock Details

EPIC MTPH
ISIN GB00BRTL9B63
Shares in Issue 33,467,507
Market cap £ 51.37m
Sector Pharmaceuticals & Biotechnology
Indices FTSE AIM All-Share Index

Financial Highlights Year Ended 31/12/2014

Turnover £0.16 million
Operating Profit £-7.89 million
Dividend Yield 0.00
Dividend Per Share 0.00
Dividend Cover 0.00
P/E Ratio -4.26
» More Financials

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Price Summary

Mid Price ? 45.50p
Bid Price ? 45.00p
Ask Price ? 46.00p
Volume ? 5622
Change Today 0.00p
% Change Today 0.00%
Open 45.00p
Previous Close 45.50p
Intraday High 45.50p
Intraday Low 45.00p
52 Week High 282.50p
52 Week Low 102.50p

Intra-Day Chart

More Charts »

Broker Consensus

The above information represents a selection of the views and target prices published in the last 120 days by analysts in individual stocks. It is subject to change without notice and may not necessarily be the view held by Redmayne-Bentley.

Client Area Access

» Secure Login

» Not registered yet?

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.